DENDREON PHARMACEUTICALS, LLC

Lobbying for DENDREON PHARMACEUTICALS, LLC

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · $59,650.00 expenses · posted Feb 25, 2026

Lobbying activity 1

Veterans

Issues related to the Department of Veterans Affairs National Oncology Program's Prostate Cancer Oncology Clinical Pathway.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.